Simpson Thacher Represents Walter Investment Management in its Acquisition of Reverse Mortgage Solutions

The Firm is representing Walter Investment Management Corp. (NYSE: WAC) (“Walter Investment”) in connection with its definitive agreement to purchase Reverse Mortgage Solutions, Inc. (“RMS”) in a transaction valued at $120 million. The consideration to be paid by Walter Investment is expected to consist of $60 million in cash, Walter Investment common stock valued at $25 million and $35 million aggregate principal amount of MSR notes of a subsidiary of Walter Investment. The transaction is subject to receipt of governmental approvals, third-party consents and other customary closing conditions. The transaction is expected to close in the fourth quarter of 2012.

More >>

Tags:  Simpson Thacher & Bartlett LLP | New York

Bass, Berry & Sims PLC Announces Key Additions to Real Estate Capital Markets Practice in Washington Office

Bass, Berry & Sims PLC today announced the addition of three experienced corporate and securities attorneys to its Washington, DC office. Samantha GallagherJustin Salon and Andy Campbell bring to Bass, Berry & Sims substantial experience representing real estate investment trusts (REITs) and national underwriters in real estate capital markets transactions. Samantha previously was a partner at the international law firm of Hogan Lovells US LLP, where Justin and Andy were associates.

More >>

Tags:  Bass, Berry & Sims, PLC

Elizabeth Scott Joins Crowe & Dunlevy

Crowe & Dunlevy is pleased to announce that Elizabeth Scott has joined the firm as a director in the healthcare, administrative and regulatory and litigation and trial practice groups in the firm’s Oklahoma City office.

More >>

Cozen O’Connor Adds Former IP Head of Novartis’ North America Generic Pharmaceutical Division to Intellectual Property Group in Chicago

Cozen O’Connor, among the 100 largest U.S. law firms, is pleased to announce that Steve Auten has joined the firm as a member of the Intellectual Property Group in Chicago. He formerly was an executive and head of intellectual property for North America with Sandoz Inc, the generic pharmaceutical division of Novartis and the world’s second largest generic pharmaceutical company.

More >>

Tags:  Cozen O'Connor, P.C.